China Startup Injects CRISPR Therapy into Human Brain for the First Time
In a groundbreaking medical first, Shanghai-based HuidaGene Therapeutics has administered a CRISPR-based therapy directly into the brain of a 9-year-old boy with MECP2...
Important Note about 23andMe
23andMe has filed for bankruptcy protection. If you—or a family member—used their services to explore your ancestry, it’s important to...